(Q35906334)

11 August 2017

1 reference

title

Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists (English)

1 reference

11 August 2017

Karim Anton Calis

1

1 reference

11 August 2017

Lisa C Hutchison

2

1 reference

11 August 2017

Mary E Elliott

3

1 reference

11 August 2017

Timothy J Ives

4

1 reference

11 August 2017

Alan J Zillich

5

1 reference

11 August 2017

Therese Poirier

6

1 reference

11 August 2017

Kevin A Townsend

7

1 reference

11 August 2017

Betsy Woodall

8

1 reference

11 August 2017

Stuart Feldman

9

1 reference

11 August 2017

Marsha A Raebel

10

1 reference

11 August 2017

American College of Clinical Pharmacy

11

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

24

1 reference

11 August 2017

issue

9

1 reference

11 August 2017

page(s)

1241-1294

1 reference

The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Evidence of the economic benefit of clinical pharmacy services: 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

The impact of pharmacist interventions on health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Consumer and provider evaluation of rural pharmacy services

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Accessibility and perceived value of health services in five western Illinois rural communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Impact of the dial access drug information service on patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Asthma in non-inner city Head Start children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Effect of a pharmacist-managed diabetes care program in a free medical clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

The effect of cimetidine on the formation of sulfamethoxazole hydroxylamine in patients with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

The effect of the new federal medical-privacy rule on research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Results of a community pharmacy-based breast cancer risk-assessment and education program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Educating the public about skin cancer prevention: a role for pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

The beneficial effects of intervention in early renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Analysis of renal bone disease treatment in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Long-term glycemic control measurements in diabetic patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Medical costs of managed care in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Medical care expenditures for diabetes, its chronic complications, and its comorbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Management of patients with type 2 diabetes by pharmacists in primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Using pharmacies in Washington state to expand access to emergency contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Improving consultations between health-care professionals and older clients: implications for pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

The benefit of implementing a heart failure disease management program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Pharmaceutical care of patients with congestive heart failure: interventions and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

A critical review of interventions to increase compliance with medication-taking, obtaining medication refills, and appointment-keeping in the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Clinical pharmacy in disease-specific clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Antiretroviral medication compliance in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Community pharmacist perspectives on HIV/AIDS and interventions for injection drug users in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Cost-effectiveness of syringe exchange as an HIV prevention strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Pharmacy and immunization services: pharmacists' participation and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

The pharmacist's role in promoting optimal antimicrobial use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

A randomized trial to measure the optimal role of the pharmacist in promoting evidence-based antibiotic use in acute care hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Drug complications in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Medication errors and adverse drug events in pediatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Pharmacist-designed and -implemented pharmaceutical care plan for antipsychotic-induced movement disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Opportunities for depression disease management: a pharmacy benefit manager's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Collaborative care model to improve outcomes in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

The role of SSRI antidepressants for treating depressed patients in the California Medicaid (Medi-Cal) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

The effects of a pharmacy-based intervention on the knowledge and attitudes of asthma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Pharmaceutical care services for asthma patients: a controlled intervention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

The Chicago Asthma Surveillance Initiative: a community-based approach to understanding asthma care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Development and implementation of a smoking cessation clinic in community pharmacy practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Results of a smoking cessation clinic in community pharmacy practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Costs and effects associated with a community pharmacy-based smoking-cessation programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

Improving drug use in rheumatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1241.38082

10.1592/PHCO.24.13.1241.38082

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference